Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 49 of GENELUX Corp's SEC filings and found 6 warrant series, 2 ATM programs, 1 shelf registration, 1 S-1 registration and 3 completed offerings on file for GNLX. The latest dilution event on file is ATM sales on Jul 31, 2026. Analysis updated Nov 1, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
TLSATiziana Life Sciences Ltd. Common Shares
TNXPTonix Pharmaceuticals Holding Corp.
CBUSCibus, Inc.
RLYBRallybio Corporation
NTHINeonc Technologies Holdings, Inc.
ATRAAtara Biotherapeutics, Inc.
MISTMilestone Pharmaceuticals Inc.
NRXSNeurAxis, Inc.
TNYATenaya Therapeutics, Inc.
VTVTvTv Therapeutics Inc.
VANIVivani Medical, Inc.
VXRTVaxart, Inc.
NTRBNutriband Inc.
UNCYUnicycive Therapeutics, Inc.
CLLSCellectis S.A. American Depositary Shares